<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665046/" ref="ordinalpos=2657&amp;ncbi_uid=1804701&amp;link_uid=PMC2665046" image-link="/pmc/articles/PMC2665046/figure/F6/" class="imagepopup">Figure 6. The control of cardiac <span class="highlight" style="background-color:">signaling</span> and hypertrophy by RF-C11.  From: Multivalency-Assisted Control of Intracellular <span class="highlight" style="background-color:">Signaling</span> Pathways: Application for Ubiquitin-Dependent N-End Rule <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">Shown is a model where RGS4, RGS5, and RGS16 are cotranslationally degraded through serial Cys-2 modifications (see the main text). In this model, the heterovalent interaction of RF-C11 to the N-recognin family inhibits the degradation of these RGS proteins in cardiomyocytes, leading to their metabolic stabilization and inactivation of G protein signaling.</div></div>